KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Cash from Discontinued Operations: 2011

Historic Cash from Discontinued Operations for Supernus Pharmaceuticals (SUPN) over the last 1 years, with Dec 2011 value amounting to -$120,000.

  • Supernus Pharmaceuticals' Cash from Discontinued Operations was N/A to -$120,000 in Q4 2011 from the same period last year, while for Dec 2011 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $2.0 million for FY2011, which is 674.15% up from last year.
  • Latest data reveals that Supernus Pharmaceuticals reported Cash from Discontinued Operations of -$120,000 as of Q4 2011, which was down 109.18% from $1.3 million recorded in Q3 2011.
  • Supernus Pharmaceuticals' Cash from Discontinued Operations' 5-year high stood at $1.7 million during Q1 2011, with a 5-year trough of -$915,000 in Q2 2011.
  • Over the past 1 years, Supernus Pharmaceuticals' median Cash from Discontinued Operations value was $593,500 (recorded in 2011), while the average stood at $505,250.